Jupiter Neurosciences, Inc.
JUNS
$1.21
$0.032.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -287.14% | -819.58% | -141.11% | -255.59% | 66.69% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 3,764.00% | 3,722.00% | 3,680.00% | 1,558.00% | 0.00% |
| Total Other Non-Cash Items | 442.82% | 181.37% | 19.41% | 2,160.61% | -63.29% |
| Change in Net Operating Assets | -118.15% | 214.92% | -168.61% | -1,665.83% | -67.48% |
| Cash from Operations | -2,610.09% | -670.42% | -1,530.37% | -2,194.10% | 73.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -98.85% | -85.64% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 5,642.31% | -85.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7,807.53% | -12,841.54% | -5,162.38% | 12,219.94% | -145.91% |